Biochemistry Quiz: Enzyme Inhibition Competitive Noncompetitive Uncompetitive Mixed

What this quiz covers

This quiz focuses on Enzyme Inhibition Competitive Noncompetitive Uncompetitive Mixed, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Measure the reaction velocity at a saturating substrate concentration in the presence of each inhibitor. (correct answer)
2. Determine the chemical structure of each inhibitor to see if it resembles the substrate.
3. Use equilibrium dialysis to measure the dissociation constant ((K_I)) for each inhibitor.
4. Perform the assay at a different pH to see if the inhibitor's binding is affected.

Explanation: The key difference is their effect at saturating substrate concentration. The inhibition by a competitive inhibitor can be completely overcome by a sufficiently high concentration of substrate, so the reaction velocity will approach the uninhibited (V_{max}). A mixed inhibitor, however, lowers the apparent (V_{max}), so even at saturating substrate concentrations, the reaction will be slower than the uninhibited (V_{max}). Measuring the rate at saturating [S] provides the most definitive distinction.

Question 2

1. An uncompetitive inhibitor that binds only to the enzyme-substrate complex. (correct answer)
2. A competitive inhibitor that allosterically alters the active site.
3. A pure noncompetitive inhibitor that affects catalysis but not binding.
4. An irreversible inhibitor that covalently modifies the enzyme.

Explanation: The key observations are: (1) binding to a site distinct from the substrate binding site (allosteric), (2) reduced catalytic turnover (decreased (V_{max})), and (3) decreased apparent (K_m). The combination of decreased (V_{max}) and decreased apparent (K_m) is the specific kinetic signature of uncompetitive inhibition, where the inhibitor binds only to the ES complex. This binding stabilizes the ES complex, effectively increasing the apparent affinity for substrate (lower (K_m)) while preventing productive catalysis (lower (V_{max})).

Question 3

1. Inhibitor Y will be more effective because its (K_I) is higher than that of Inhibitor X.
2. Inhibitor X will cause a larger increase in the apparent (K_m) than Inhibitor Y. (correct answer)
3. Both inhibitors will increase the apparent (K_m) to the same value because they are at the same concentration.
4. Neither inhibitor will have a significant effect, as their concentrations are equal to or less than their (K_I) values.

Explanation: When you encounter competitive inhibition problems, focus on how inhibitors affect the apparent $K_m$ based on their binding affinity ($K_I$) and concentration. For competitive inhibition, the apparent $K_m$ increases according to: $K_m^{app} = K_m(1 + \frac{[I]}{K_I})$ Let's calculate the apparent $K_m$ for each inhibitor at 10 μM concentration: For Inhibitor X: $K_m^{app} = 5(1 + \frac{10}{10}) = 5(1 + 1) = 10 \text{ μM}$ For Inhibitor Y: $K_m^{app} = 5(1 + \frac{10}{20}) = 5(1 + 0.5) = 7.5 \text{ μM}$ Inhibitor X causes a larger increase in apparent $K_m$ (from 5 to 10 μM) compared to Inhibitor Y (from 5 to 7.5 μM), confirming answer B is correct. Answer A is wrong because lower $K_I$ values indicate stronger binding and greater inhibitory effectiveness, not higher values. Answer C incorrectly assumes that equal inhibitor concentrations produce equal effects—the $K_I$ values determine the relative effectiveness. Answer D is incorrect because both inhibitors have significant effects; the concentration doesn't need to exceed $K_I$ to cause inhibition. Study tip: Remember that competitive inhibition effectiveness depends on the ratio $\frac{[I]}{K_I}$. Lower $K_I$ means stronger binding, so always compare this ratio rather than just concentrations or $K_I$ values alone.

Question 4

1. A classic noncompetitive inhibitor.
2. A potent competitive inhibitor. (correct answer)
3. A typical uncompetitive inhibitor.
4. An irreversible covalent inhibitor.

Explanation: When analyzing enzyme inhibition, you need to consider three key factors: the inhibitor's structure relative to the substrate, where it binds, and whether substrate concentration can overcome the inhibition. Methotrexate demonstrates classic competitive inhibition characteristics. As a structural analog of dihydrofolate, it mimics the natural substrate's shape, allowing it to bind directly to the enzyme's active site. The crucial clue is that increasing dihydrofolate concentration can restore maximal reaction velocity - this is the hallmark of competitive inhibition. When substrate concentration becomes high enough, it can outcompete the inhibitor for the active site, eventually achieving normal $V_{max}$. Looking at the incorrect options: A) Noncompetitive inhibitors bind to allosteric sites, not the active site, and increasing substrate concentration cannot restore $V_{max}$. Since methotrexate binds to the active site and substrate can overcome inhibition, this doesn't fit. C) Uncompetitive inhibitors only bind to the enzyme-substrate complex, not the free enzyme. The question describes binding to the enzyme's active site, indicating direct competition with substrate. D) Irreversible covalent inhibitors form permanent bonds with the enzyme. However, the ability to restore activity by increasing substrate concentration indicates the inhibition is reversible. The 1000-fold higher affinity simply makes methotrexate a particularly potent competitive inhibitor, not a different type of inhibition. Remember: if an inhibitor is a structural analog that binds the active site and can be overcome by excess substrate, think competitive inhibition first.

Question 5

1. Competitive, because the inhibitor increases the apparent affinity of the enzyme for the substrate.
2. Uncompetitive, because both the maximal velocity and the apparent (K_m) are decreased.
3. Mixed, because the inhibitor affects the catalytic rate but has a different affinity for E and ES.
4. Noncompetitive, because the inhibitor reduces the catalytic rate without affecting substrate binding to the active site. (correct answer)

Explanation: The data show that the apparent (K_m) is unchanged (15 μM) while the apparent (k_{cat}), which determines (V_{max}), is decreased (from 200 to 50 s⁻¹). This specific kinetic signature—a decrease in (V_{max}) with no change in (K_m)—is characteristic of pure noncompetitive inhibition. This occurs when the inhibitor binds with equal affinity to the free enzyme (E) and the enzyme-substrate complex (ES), affecting catalysis but not the apparent substrate binding.

Question 6

1. Apparent (K_m) increases and apparent (V_{max}) decreases. (correct answer)
2. Apparent (K_m) decreases and apparent (V_{max}) decreases.
3. Apparent (K_m) is unchanged and apparent (V_{max}) decreases.
4. Apparent (K_m) increases and apparent (V_{max}) is unchanged.

Explanation: The condition (K_I < K_I') means the inhibitor has a higher affinity (binds more tightly) to the free enzyme (E) than to the enzyme-substrate complex (ES). Binding to free E effectively removes it from the pool available to bind substrate, which resembles competitive inhibition. This component increases the apparent (K_m). Since it is a mixed inhibitor, it also binds ES and reduces the catalytic rate, causing a decrease in apparent (V_{max}).

Question 7

1. When cellular concentrations of the enzyme's substrate are significantly below the (K_m).
2. When cellular concentrations of the enzyme's substrate are near the (K_m).
3. When cellular concentrations of the enzyme's substrate are significantly above the (K_m). (correct answer)
4. When the enzyme concentration is significantly higher than the substrate concentration.

Explanation: Uncompetitive inhibitors bind exclusively to the enzyme-substrate (ES) complex. The concentration of the ES complex is highest when the substrate concentration is high and saturating (significantly above the (K_m)). Therefore, an uncompetitive inhibitor will be most effective under these conditions, as its target (the ES complex) is most abundant.

Question 8

1. Compound A is competitive, while Compound B could be noncompetitive or uncompetitive. (correct answer)
2. Compound A is uncompetitive, while Compound B is competitive.
3. Both compounds are competitive, but Compound B has a much lower (K_I).
4. Compound A is noncompetitive, while Compound B is an irreversible inhibitor.

Explanation: The ability to overcome inhibition by increasing substrate concentration is the defining characteristic of competitive inhibition. Since the effect of Compound A is overcome at high [S], it must be a competitive inhibitor. Inhibition that persists at high [S] indicates that (V_{max}) has been lowered. Both noncompetitive and uncompetitive inhibitors lower (V_{max}). Therefore, Compound B belongs to one of these classes.

Question 9

1. The inhibitor binds to the ES complex, and by Le Châtelier's principle, pulls the E + S ⇌ ES equilibrium to the right. (correct answer)
2. The inhibitor binds to the free enzyme, inducing a conformational change that increases its affinity for the substrate.
3. The inhibitor is a structural analog of the substrate and binds to the active site, thereby lowering the (K_m).
4. The decrease in (V_{max}) caused by the inhibitor directly causes a proportional decrease in the apparent (K_m).

Explanation: An uncompetitive inhibitor binds only to the ES complex, forming an unproductive ESI complex. The removal of ES from the equilibrium E + S ⇌ ES causes the equilibrium to shift to the right to replenish the ES complex. This sequestration of the ES complex manifests kinetically as an increased apparent affinity of the enzyme for its substrate, resulting in a lower apparent (K_m).

Question 10

1. Apparent (V_{max}) will decrease, and the effect on apparent (K_m) is unpredictable without more information. (correct answer)
2. Apparent (V_{max}) will be unchanged, and apparent (K_m) will increase.
3. Apparent (V_{max}) will decrease, and apparent (K_m) will also decrease.
4. Both apparent (V_{max}) and apparent (K_m) will increase.

Explanation: The competitive inhibitor (X) increases apparent (K_m) and does not affect (V_{max}). The uncompetitive inhibitor (Y) decreases both apparent (K_m) and apparent (V_{max}). When combined, only Drug Y affects (V_{max}), so the apparent (V_{max}) will definitively decrease. However, the two drugs have opposing effects on apparent (K_m). The final value will depend on the relative concentrations and binding affinities ((K_I)) of the two inhibitors, making the net effect on (K_m) unpredictable.

Question 11

1. Competitive inhibition. (correct answer)
2. Noncompetitive inhibition.
3. Uncompetitive inhibition.
4. Irreversible inhibition.

Explanation: On a Lineweaver-Burk plot, the y-intercept is equal to 1/(V_{max}). If the lines for the uninhibited and inhibited reactions intersect on the y-axis, it means that the y-intercept is the same for all inhibitor concentrations, and therefore (V_{max}) is unchanged. A change in the slope ((K_m)/(V_{max})) and x-intercept (-1/(K_m)) with a constant (V_{max}) is the defining kinetic signature of competitive inhibition.

Question 12

1. The inhibitor binds to the active site, preventing the substrate from binding and thus lowering the effective enzyme concentration.
2. The inhibitor binds to the enzyme-substrate complex, shifting the reaction equilibrium away from product formation.
3. The inhibitor binds to an allosteric site on both E and ES, effectively removing a fraction of the enzyme from catalysis regardless of substrate concentration. (correct answer)
4. The inhibitor increases the apparent (K_m) so dramatically that the enzyme can never reach its theoretical maximal velocity.

Explanation: A pure noncompetitive inhibitor binds to an allosteric site with equal affinity for both the free enzyme (E) and the enzyme-substrate complex (ES). This binding does not prevent substrate binding but it renders the enzyme catalytically inactive. Thus, it effectively lowers the concentration of functional enzyme ([E]T), which directly leads to a decrease in the apparent (V_{max}) (since (V_{max} = k_{cat}[E]_T)). This effect cannot be overcome by high substrate concentration.

Question 13

1. Competitive inhibitor.
2. Noncompetitive inhibitor.
3. Uncompetitive inhibitor.
4. Mixed inhibitor. (correct answer)

Explanation: The lack of structural similarity and the nature of feedback regulation strongly suggest binding to an allosteric site, ruling out simple competitive inhibition. The kinetic data show a decrease in (V_{max}) and an increase in apparent (K_m). This specific combination of effects is characteristic of mixed inhibition (specifically, the case where the inhibitor has a higher affinity for the free enzyme than for the ES complex).

Question 14

1. The inhibitor is noncompetitive, and the apparent (K_m) is unchanged.
2. The inhibitor is competitive, and the apparent (V_{max}) is unchanged. (correct answer)
3. The inhibitor is uncompetitive, and the apparent (K_m) is decreased.
4. The inhibitor is mixed, and the apparent (V_{max}) is decreased.

Explanation: When you encounter enzyme inhibition problems, focus on the key clue: whether excess substrate can displace the inhibitor. This tells you about the binding mechanism and predicts specific kinetic effects. If a large excess of substrate can completely displace an inhibitor, the inhibitor must be competing with the substrate for the same binding site—the enzyme's active site. This is the definition of competitive inhibition. In competitive inhibition, the inhibitor and substrate cannot bind simultaneously because they occupy the same location. When competitive inhibition occurs, it appears harder for the substrate to bind (increasing apparent $K_m$), but once substrate does bind, the enzyme functions normally. Therefore, $V_{max}$ remains unchanged because at saturating substrate concentrations, virtually all inhibitor is displaced and the enzyme reaches its full catalytic potential. Answer A incorrectly describes noncompetitive inhibition, where the inhibitor binds to a different site than the substrate. In this case, excess substrate cannot displace the inhibitor, and $K_m$ typically remains unchanged while $V_{max}$ decreases. Answer C describes uncompetitive inhibition, where the inhibitor only binds to the enzyme-substrate complex. Here, substrate cannot displace the inhibitor either, and $K_m$ actually decreases. Answer D refers to mixed inhibition, a combination mechanism where the inhibitor affects both $K_m$ and $V_{max}$, but again, substrate excess cannot fully displace it. Study tip: Remember the displacement test—only competitive inhibitors can be overcome by excess substrate because they compete for the same binding site.

Question 15

1. 2.5 mM (correct answer)
2. 5.0 mM
3. 7.5 mM
4. 10.0 mM

Explanation: This is competitive inhibition since $K_m$ increases while $V_{max}$ remains constant. For competitive inhibition: $K_m^{app} = K_m(1 + [I]/K_i)$. Substituting: $6.0 = 2.0(1 + 5.0/K_i)$. Solving: $3.0 = 1 + 5.0/K_i$, so $2.0 = 5.0/K_i$, therefore $K_i = 2.5$ mM. Choice B incorrectly assumes $K_i = [I]$. Choice C results from algebraic error (adding instead of subtracting 1). Choice D comes from incorrect formula manipulation.

Question 16

1. The inhibitor shows pure competitive inhibition but has extremely high binding affinity (very low $K_i$)
2. The inhibitor exhibits mixed inhibition with strong competitive character ($K_{is} << K_{ii}$) (correct answer)
3. The enzyme shows negative cooperativity that interferes with normal competitive inhibition kinetics
4. The inhibitor causes partial uncompetitive inhibition that becomes competitive at high substrate concentrations

Explanation: Mixed inhibition with $K_{is} << K_{ii}$ appears nearly competitive because the inhibitor binds much more weakly to ES complex. However, some inhibitor still binds to ES, requiring higher substrate concentrations than pure competitive inhibition to achieve complete reversal. Choice A would show normal competitive behavior. Choice C doesn't explain the inhibition pattern. Choice D incorrectly describes uncompetitive inhibition, which cannot be overcome by substrate.

Question 17

1. Reversible mixed inhibition with extremely high binding affinity due to multiple weak interactions
2. Competitive inhibition complicated by slow substrate binding kinetics in the assay conditions
3. Irreversible covalent modification that appears reversible due to slow enzyme turnover
4. Slow-binding inhibition involving induced fit conformational changes in the enzyme-inhibitor complex (correct answer)

Explanation: When analyzing enzyme inhibition kinetics, pay close attention to the combination of reversibility characteristics and time-dependent behavior. This question tests your understanding of slow-binding inhibition, a special case where initial binding is followed by a slow conformational change. The key evidence pointing to slow-binding inhibition includes: the extremely slow reversal kinetics (half-life > 2 hours), complete reversibility upon washing, mixed inhibition pattern, and very low apparent $K_i$ values. In slow-binding inhibition, the inhibitor first binds rapidly to form an initial complex, then undergoes a slow conformational rearrangement to form a much tighter, more stable complex. This explains both the high apparent affinity (low $K_i$) and the slow dissociation kinetics. Option A is incorrect because standard reversible inhibition, even with high affinity, wouldn't show such dramatically slow reversal kinetics. The binding and unbinding rates would be much faster. Option B is wrong because competitive inhibition wouldn't produce a mixed inhibition pattern, and slow substrate binding wouldn't affect inhibitor dissociation rates during washing when no substrate is present. Option C is incorrect because truly irreversible covalent modification wouldn't be reversible by simple washing, regardless of enzyme turnover rates. Remember that slow-binding inhibition is characterized by time-dependent inhibition that appears much tighter than initial rapid equilibrium measurements suggest. Look for the combination of reversibility, slow kinetics, and unusually tight apparent binding - these are hallmarks of conformational changes stabilizing the enzyme-inhibitor complex.

Question 18

1. Pure competitive inhibition since substrate and inhibitor compete for the same binding sites
2. Uncompetitive inhibition since the inhibitor can only bind after substrate binding occurs
3. Mixed inhibition with unusual concentration dependence due to the asymmetric binding constraint (correct answer)
4. Noncompetitive inhibition with reduced cooperativity due to inhibitor binding to free subunits

Explanation: The asymmetric binding creates a complex mechanism where inhibitor affects both free enzyme (reducing substrate binding) and ES complex (preventing formation of ES₂), characteristic of mixed inhibition. The constraint that inhibitor binds only to one subunit creates unusual concentration dependencies not seen in simple mixed inhibition. Choice A ignores the ESI complex formation. Choice B is incorrect since inhibitor can bind to free enzyme. Choice D doesn't account for the mixed binding pattern described.

Question 19

1. Competitive inhibition that disrupts positive cooperativity by binding to the same site as substrate
2. Uncompetitive inhibition that selectively targets highly cooperative enzyme-substrate complexes
3. Mixed inhibition with preferential binding to the low-affinity conformational state
4. Allosteric inhibition that reduces cooperativity without affecting the catalytic mechanism (correct answer)

Explanation: When you encounter questions about enzyme cooperativity and inhibition mechanisms, focus on how the Hill coefficient and kinetic parameters change together to reveal the underlying mechanism. This enzyme shows positive cooperativity (Hill coefficient = 2.8), meaning subunits communicate to enhance substrate binding. When inhibitor Q is added, three key changes occur: the Hill coefficient drops to 1.9, $K_{0.5}$ increases, and $V_{max}$ stays constant. This pattern points to reduced cooperativity without affecting the catalytic machinery itself. Answer D correctly identifies allosteric inhibition that reduces cooperativity. The inhibitor binds to an allosteric site (not the active site), disrupting the cooperative communication between subunits. This explains why cooperativity decreases (lower Hill coefficient) and why more substrate is needed for half-maximal binding (higher $K_{0.5}$). Since the active sites remain unaffected, $V_{max}$ stays unchanged. Answer A is wrong because competitive inhibition would show changed $K_{0.5}$ but typically wouldn't dramatically alter cooperativity patterns. Answer B incorrectly describes uncompetitive inhibition, which would decrease $V_{max}$ since it removes enzyme-substrate complexes from the catalytic cycle. Answer C describes mixed inhibition, which would also typically affect $V_{max}$ due to binding at the active site. Remember this pattern: when you see decreased cooperativity (lower Hill coefficient) with unchanged $V_{max}$ but altered binding affinity, think allosteric effects that disrupt subunit communication without touching the catalytic mechanism.

Question 20

1. $K_{is} = 2$ mM and $K_{ii} = 2$ mM, indicating equal binding affinity to both forms
2. $K_{is} = 4$ mM and $K_{ii} = 2$ mM, indicating stronger binding to enzyme-substrate complex (correct answer)
3. $K_{is} = 2$ mM and $K_{ii} = 4$ mM, indicating stronger binding to free enzyme
4. $K_{is} = 1$ mM and $K_{ii} = 6$ mM, indicating much stronger binding to free enzyme

Explanation: For mixed inhibition: $K_m^{app} = K_m \frac{1 + [I]/K_{is}}{1 + [I]/K_{ii}}$ and $V_{max}^{app} = \frac{V_{max}}{1 + [I]/K_{ii}}$. From $V_{max}$ data: $40 = 80/(1 + 2/K_{ii})$, so $K_{ii} = 2$ mM. From $K_m$ data: $2 = 4 \frac{1 + 2/K_{is}}{1 + 2/2} = 4 \frac{1 + 2/K_{is}}{2}$, solving gives $K_{is} = 4$ mM. Since $K_{ii} < K_{is}$, the inhibitor binds more tightly to ES complex. Other choices contain calculation errors.